Track topics on Twitter Track topics that are important to you
In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global Thebaine market for 20182023.
Thebaine, also known as paramorphine, is a white, crystalline, slightly watersoluble in pure form after a synthesis, poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum Iranian poppy, it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.
Currently, because of the special properties of thebaine, subject to strict control in most countries, so the market production control by the country's policy.
Thebaine production industry is a highly profitable industry. In the United States and other regions, more and more enterprises begin to apply to enter this field, but the current situation, the market is still controlled by the Mallinckrodt Pharmaceuticals and Noramco.
But as the downstream drugs market gradually matures, the next few years, thebaine and his relevant market will gradually popular, so the next few years, thebaine have a certain degree of price rise, but the rate should be minimal
Over the next five years, LPILP Information projects that Thebaine will register a 1.1% CAGR in terms of revenue, reach US$ 1240 million by 2023, from US$ 1160 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Thebaine market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Segmentation by application:
This report also splits the market by region:
Middle East Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Faran Shimi Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Thebaine consumption value volume by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Thebaine market by identifying its various subsegments.
Focuses on the key global Thebaine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Thebaine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
To project the consumption of Thebaine submarkets, with respect to key regions along with their respective key countries.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...